Trade

with

Qiagen NV
(NASDAQ: QGEN)
AdChoices
22.84
-0.07
-0.31%
After Hours :
22.84
0.00
0.00%

Open

22.86

Previous Close

22.91

Volume (Avg)

866.99k (830.59k)

Day's Range

22.75-22.97

52Wk Range

19.46-25.32

Market Cap.

5.49B

Dividend Rate ( Yield )

-

Beta

0.89

Shares Outstanding

239.71M

P/E Ratio (EPS)

35.97 (0.64)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Diagnostics & Research
Highlights
Analyst Recommendation: Underperform
    • Revenue

    • 1.30B

    • Net Income

    • 69.07M

    • Market Cap.

    • 5.49B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 11.79

    • PEG (Price/Earnings Growth) Ratio

    • 2.09

    • Beta

    • 0.89

    • Forward P/E

    • 19.57

    • Price/Sales

    • 4.22

    • Price/Book Value

    • 1.99

    • Price/Cash flow

    • 19.57

      • EBITDA

      • 267.58M

      • Return on Capital %

      • 3.68

      • Return on Equity %

      • 5.89

      • Return on Assets %

      • 3.68

      • Book Value/Share

      • 11.45

      • Shares Outstanding

      • 239.71M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Underperform
        • 1 Year Price Target

        • 17.50

        • Credit Rating

        • -

        • Analysts

        • 3

        • EPS Estimate

        • 0.67

        • Cashflow Estimate

        • 1.45

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 5.00

          • 21.91

          • Net Income

            YTD/YTD (last year)

          • -46.70

          • -5.55

          • Net Income

            Q/Q (last year)

          • -

          • 0.44

          • Sales (Revenue)

            5-Year Annual Average

          • 7.83

          • 47.82

          • Net Income

            5-Year Annual Average

          • -5.00

          • 4.98

          • Dividends

            5-Year Annual Average

          • -

          • 5.31

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 65.55

            • 42.70

            • Pre-Tax Margin

            • 9.63

            • 11.63

            • Net Profit Margin

            • 11.79

            • 9.55

            • Average Gross Margin

              5-Year Annual Average

            • 64.90

            • 43.76

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 11.10

            • 11.34

            • Average Net Profit Margin

              5-Year Annual Average

            • 10.20

            • 52.13B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.43

              • 0.62

              • Current Ratio

              • 4.06

              • 1.23

              • Quick Ratio

              • 3.22

              • 0.76

              • Interest Coverage

              • 4.78

              • 5.98

              • Leverage Ratio

              • 1.66

              • 2.16

              • Book Value/Share

              • 11.45

              • 14.94

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 35.46

                • 33.22

                • P/E Ratio 5-Year High

                • 39.72

                • 325.07

                • P/E Ratio 5-Year Low

                • 19.56

                • 154.73

                • Price/Sales Ratio

                • 4.18

                • 2.34

                • Price/Book Value

                • 1.97

                • 3.04

                • Price/Cash Flow Ratio

                • 19.57

                • 19.08

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 5.89

                    (4.90)

                  • 9.34

                    (9.80)

                  • Return on Assets %

                    (5-Year Average)

                  • 3.68

                    (3.10)

                  • 4.63

                    (5.44)

                  • Return on Capital %

                    (5-Year Average)

                  • 4.98

                    (2.90)

                  • 5.73

                    (6.77)

                  • Income/Employee

                  • 37.37k

                  • 17.17k

                  • Inventory Turnover

                  • 3.42

                  • 5.07

                  • Asset Turnover

                  • 0.31

                  • 0.48

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  63.33M
                  Operating Margin
                  4.86
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  19.57
                  Ownership

                  Institutional Ownership

                  66.27%

                  Top 10 Institutions

                  30.81%

                  Mutual Fund Ownership

                  45.68%

                  Float

                  96.77%

                  5% / Insider Ownership

                  -

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard Capital Opportunity Fund

                  •  

                    8,280,000

                  • 0.36

                  • 3.49

                  • AMP Platinum International

                  •  

                    5,759,254

                  • 0.00

                  • 2.40

                  • PrimeCap Odyssey Aggressive Growth Fund

                  •  

                    5,491,114

                  • -0.73

                  • 2.31

                  • Manning & Napier World Opp Ser Fd

                  •  

                    3,642,027

                  • -19.03

                  • 1.50

                  • Templeton Growth Fund

                  •  

                    3,422,165

                  • 8.70

                  • 1.42

                  • PrimeCap Odyssey Growth Fund

                  •  

                    3,296,614

                  • 0.00

                  • 1.39

                  • iShares Nasdaq Biotechnology

                  •  

                    3,008,712

                  • -0.47

                  • 1.26

                  • Templeton ForeignFund

                  •  

                    2,945,420

                  • 192.53

                  • 1.22

                  • First Trust NYSE Arca Biotech Fund

                  •  

                    2,394,220

                  • 2.03

                  • 1.00

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • PRIMECAP Management Company

                  •  

                    22,087,404

                  • -0.66%

                  • 9.30

                  • Harding Loevner L.P.

                  •  

                    6,978,369

                  • +0.23%

                  • 2.94

                  • Platinum Asset Management

                  •  

                    6,135,404

                  • 0.00%

                  • 2.56

                  • Baillie Gifford & Co Limited.

                  •  

                    5,817,688

                  • +2.57%

                  • 2.45

                  • Government Pension Fund of Norway - Global

                  •  

                    5,131,418

                  • +43.74%

                  • 2.19

                  • Johnston Asset Mgmt. Corp.

                  •  

                    4,586,856

                  • +23.20%

                  • 1.93

                  • BlackRock Fund Advisors

                  •  

                    4,399,963

                  • -0.67%

                  • 1.85

                  • Credit Agricole Asset Management Group

                  •  

                    4,364,313

                  • +1.65%

                  • 1.84

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Diagnostics & Research

                  Type

                  Classic Growth

                  Style

                  Mid Core

                  Qiagen NV provides Sample & Assay Technologies, based on market studies of United States and European market shares for its products and technologies. It also offers kits, assays, related automated systems and bioinformatics solutio...morens, that cover the entire continuum from basic life sciences research to clinical diagnostics. The Company markets more than 500 core products that are distributed in thousands of variations and combinations. In October 2012, the company announced a collaboration with Bayer HealthCare for development and commercialization of companion diagnostics paired with novel Bayer drugs, initially to enhance the treatment of various solid tumors. The Company has developed and advanced a broad range of technologies to extract and purify molecules of interest from biological samples ...moresuch as blood, bone, tissue. It has also developed assays that enable the analysis of various kinds of molecules from virtually any biological sample. Assay technologies make information contained in isolated molecules visible and available for interpretation. The Company sells varied and flexible workflows for molecular testing, including sample and assay kits known as consumables and automated instrumentation platforms using those technologies, to four major customer classes: Molecular Diagnostics - healthcare providers supporting many aspects of patient care including prevention, profiling of diseases, personalized healthcare and point of need testing; Applied Testing - government or industry customers using molecular technologies in fields such as forensics, veterinary diagnostics and food safety testing; Pharma - drug discovery, translational medicine and clinical development efforts of pharmaceutical and biotechnology companies; Academia - researchers exploring the secrets of life such as the mechanisms and pathways of diseases. The Company markets its products in more than 100 countries throughout the world. The Company’s competitors includes Promega Corp., EMD Millipore or Merck Millipore, and Macherey-Nagel GmbH for nucleic acid separation and purification; Thermo Fisher and Promega Corp. for assay solutions and for transfection reagents; and Sigma-Aldrich Corp. and Thermo Fisher for protein fractionation products. The Company is subject to a variety of laws and regulations in the European Union, the United States and other countries.lessless

                  Key People

                  Peer M. Schatz

                  CEO/Managing Director

                  ProfessorDr. Detlev H. Riesner,PhD

                  Chairman of Supervisory Board/Co-Founder

                  Roland Sackers

                  CFO/Managing Director

                  Ms. Elizabeth E. Tallett

                  Director

                  Professor Dr. Manfred Karobath

                  Director

                  • Qiagen NV

                  • Spoorstraat 50

                  • Venlo, 5911 KJ

                  • NLD.Map

                  • Phone: +31 773208400

                  • Fax: +31 773208409

                  • qiagen.com

                  Incorporated

                  1996

                  Employees

                  4,200

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: